跳至主要内容
临床试验/CTRI/2017/09/009673
CTRI/2017/09/009673已完成4 期

Comparison of anti-platelet efficacy of four different marketed formulations of Aspirin in diabetic patients.

Dr Kanharam Patel0 个研究点目标入组 121 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
121

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with Type 2 DM receiving oral anti-diabetic with dietary modifications and who have two or more risk factors for cardiovascular disease.

排除标准

  • Patients having age <40 yrs.
  • Uncontrolled diabetes mellitus (Fasting BSL > 300 mg/dL Despite therapy)
  • Uncontrolled Hypertension
  • Abnormal Liver Function Tests and/or Renal Function Tests.
  • Patients receiving any form or dose of Aspirin therapy for >7 days
  • Patient receiving any other antithrombotic or anti-coagulant therapy.
  • Patients having deranged bleeding and/ or clotting time at baseline study.
  • Patient on insulin.

研究者

发起方
Dr Kanharam Patel

相似试验